New Jersey’s Psilocybin Pilot: What the Law Actually Says

New Jersey passes a bill opening the door to legal psychedelic therapy. - psychologytoday.com

New Jersey has passed a bill establishing a supervised psilocybin therapy pilot program, according to a January 2026 report in Psychology Today. The legislation creates a legal framework for structured, facilitated access to psilocybin in the state. This is a policy development, not a clinical finding, and no therapeutic outcomes data are attached to it. […]

Minnesota Psilocybin Research Bill: What Lawmakers Approved

Minnesota psilocybin research bill: Minnesota Psilocybin Research Bill: What Lawmakers Approved

Minnesota state lawmakers are on the verge of approving legislation that would authorize federally funded psilocybin research. The bill does not legalize psilocybin for general use. It is a policy development, not a clinical finding, and reflects a cautious legislative step toward structured scientific inquiry at the state level. Key takeaways The Minnesota legislation, as […]

Psilocybin for PTSD: Trials, Laws, and Early Evidence

Psilocybin for PTSD: Trials, Laws, and Early Evidence

In January 2026, the FDA accepted Compass Pathways’ Investigational New Drug Application to study its synthetic psilocybin compound, COMP360, as a possible therapy for PTSD. A separate randomized controlled trial at Johns Hopkins has also recently completed. Both are early-stage investigations, and no treatment has been approved. Key takeaways A late-stage trial is now authorized. […]